Conference Coverage

MOMENTUM 3 HeartMate 3 LVAD ‘practice changing’

Dr. Hossein Almassi, FCCP

G. Hossein Almassi, MD, FCCP, comments: The reported 2- year follow-up results of MOMENTUM 3 trial on the new generation HeatMate-III magnetically levitated LVAD gives more hope to patients with end-stage heart failure for a better quality of life and longer survival and opens new doors for potentially becoming an alternative to cardiac transplantation for patients with a long waiting time on the transplant list.



SOURCE: Mehra M et al. ACC 18.

Next Article: